PROVIDER PROFILE · NPI 1922082247

Yoav HahnMD

OtolaryngologyDallas, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

818

Unique beneficiaries

—

Total services

977

Distinct HCPCS

Medicare payment

$59K

Peer benchmark

Total Medicare services vs. 668 Otolaryngology providers in TX — above median (cohort median 967).

PRESCRIBING · PART D · 2024

Total Rx claims

161

Beneficiaries

—

Total drug cost

$5K

Distinct drugs

Brand share

34.8%

Top prescribed drugs

Ciprofloxacin Hcl46 claims

Ciprofloxacin Hcl/Dexameth39 claims

Clonazepam24 claims

Cephalexin21 claims

Hydrocodone/Acetaminophen17 claims

QUALITY · MIPS · 2024

Final MIPS score

84.2

Quality

82.1

Cost

71.2

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

0.39%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$1K

Payment records

By payment type

Travel and Lodging$1K

Food and Beverage$459

REFERRAL NETWORK

Where Yoav Hahn's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Laboratory Corporation Of America Clinical Laboratory · Dallas, TX	36	75
Medical City Dallas Imaging Center, Llc Independent Diagnostic Testing Facility (IDTF) · Dallas, TX	22	43
Brian Peters Otolaryngology · Dallas, TX	17	25
Clinical Pathology Laboratories, Inc. Clinical Laboratory · Austin, TX	15	20

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history